Actively Recruiting
OsteoArticular Sepsis in Intensive Care unitS
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2025-07-14
150
Participants Needed
1
Research Sites
17 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is an ambispective observational study of patients admitted to intensive care with a diagnosis of joint prosthesis infection (mainly knee and hip prostheses). The main objective of the study is to describe the profile, care trajectories during the stay (before or after surgery) and prognosis of patients admitted to critical care with such an infection. We also aim to compare prognosis between different groups of patients sharing the same profile and care trajectory, and to assess independent risk factors associated with 2-year mortality among the study population. Finally, we will describe the microbiological and resistance profile of severe osteoarticular device infections requiring critical care admission in France. This is a descriptive and analytical observational study open to all French public and private hospitals. Patient data will be retrieved prospectively from patient source files. Only 2-year data (vital status, functional data) will be collected specifically for the study, by telephone contact with the patient or his or her support person.
CONDITIONS
Official Title
OsteoArticular Sepsis in Intensive Care unitS
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient at least 18 years old.
- Hospitalization in critical care (intensive care unit or continuing care unit) between 2018 and 2022 of at least 48 hours, with prosthetic joint infection (hip, knee or shoulder prosthesis infection) as the main or associated diagnosis.
You will not qualify if you...
- Infection on osteosynthesis material.
- Infection on spinal equipment.
- Patient with several infected prostheses.
- Recurrence of infection on prosthesis with the same microorganism.
- Patient opposing data collection.
- Patient under legal protection.
- Pregnant or breast-feeding patient.
- Patient deprived of liberty.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hôpital Lariboisière
Paris, France, France, 75010
Actively Recruiting
Research Team
B
Benjamin SOYER, MD, Msc
CONTACT
B
Benjamin G CHOUSTERMAN, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here